View
222
Download
4
Category
Preview:
Citation preview
Bases de données observationnelles AC12
Bilan 2007 et Objectifs 2008
Le modèle originel :Antiretroviral Therapy (ART)Cohort Collaboration
• France• French Hospital Database on HIV (FHDH)• Aquitaine Cohort
• Germany• Frankfurt HIV Cohort • Köln / Bonn Cohort
• Italy• Italian Cohort of Antiretroviral-Naive Patients (ICONA)
• Switzerland• Swiss HIV Cohort Study
• Netherlands• AIDS Therapy Evaluation project Netherlands (ATHENA)
• Spain• PISCIS, Catalonia and Balearic islands
• United Kingdom• Royal Free Hospital Cohort, London
• The Multicenter Study Group on EuroSIDA• 29 European countries
• Canada• British Columbia Centre for Excellence in HIV (BCCfE-HIV)• South Alberta Clinic
• USA• Collaborations in HIV Outcomes Research US (CHORUS)• 1917 Clinic Cohort, University of Alabama, Birmingham • University of Washington HIV Cohort, Seattle• Veterans Aging Cohort Study (VACS), West Haven
www.art-cohort-collaboration.org
ARTCohort Collaboration
The Antiretroviral Therapy in Low-Income Countries (ART-LINC) Collaboration
ANRS 12101 / 12138 & NIH/OARDabis, Egger, Schechter
• A network of 21 HIV treatment programs and 47 clinical centers in Africa (Morocco, Senegal, Côte d’Ivoire, Nigeria, Cameroon, Uganda, Malawi, South Africa, Botswana), Latin America (Argentina, Brazil), and Asia (India, Thailand)
– Sites identified through literature searches and personal contacts• Site assessments conducted through self-administered surveys and on-site
assessments by ART-LINC central team (2004 and 2006) and through an electronic system DataCol ® (2008)
– Pooling of existing databases with individual patient data:• Merger # 1 : 2004-2005, N = 8.700
• Merger # 2 : 2006-2007, N = 40,000
Number of patients receiving ART (A); Proportion of women (B);Median baseline CD4 (C); Proportion with viral load (D) - Kaiser (CROI 2008)
Mortality over four years
Sub-Saharan Africa
Europe & North America
Months after start of ART
0 12 24 36 48
Cum
ulat
ive
mor
talit
y (%
)
0
5
10
15
CROI 2007 – Egger Plenary
Sustained long‑term CD4 response to ART among naïve patients in low‑income countries
Denis Nash - CROI 2008
114
263
230
395366377376372
355336
301
0
50
100
150
200
250
300
350
400
450
Baseline 1 2 3 4 5
Sustained long‑term CD4 response to ART among naïve patients in low‑income countries
D. Nash - CROI 2008Most important determinant of CD4 trajectory after ART initiation is
baseline CD4 (increasing with calendar time at most sites)
0
100
200
300
400
500
600
700
Baseline 1 2 3 4 5
Missing0-<2425-4950-99100-149150-199200-299300+
Higher incidence in lower-income countries(7.4 vs 1.0 per 100 PY) but relative reduction over time is comparable and low CD4 is the most important risk factor
QuickTime™ et undécompresseur TIFF (non compressé)
sont requis pour visionner cette image.
Tuberculosis in the first year after Initiation of ART in Low-Income and High-Income CountriesThe ART-LINC Collaboration and The ART Cohort Collaboration
CID 2007:45 (1 December)
Probability of death or lost-to-follow-up in 2,710 adults starting ART at WHO stage 1 or 2 and CD4 >200/mm3 or unknown,
according to CTX prescription (C. Lewden in progress)
CTX+HAART Only HAART
De
ath
or
loss
to fo
llow
-up
pro
ba
bili
ty
0.00
0.04
0.08
0.12
0.16
0.20
Time (months)
0 6 12 18 24
P=0.006
Adjusted HR: 046 (0.30-0.73)
Coût-efficacité de stratégies de rétention des patients sous ART
Hapsatou Touré, Xavier Anglaret, Elena LosinaFrançois Dabis, Ken Freedberg
Objectif général
Comparer l’efficacité et les ratios de coût/efficacité de stratégies actives de recherche de patients, initialement sous traitement antirétroviral, perdus de vue dans des cohortes sélectionnées de pays à ressources limitées (Abidjan, Cape Town, …)
ART-LINC: Box 5, P. 28-29
QuickTime™ et undécompresseur TIFF (LZW)
sont requis pour visionner cette image.
International epidemiological Databases to Evaluate AIDS
• 7 regional networks• North America• South America / Caribbean• West Africa• Central Africa• East Africa• Southern Africa• Australia / Asia
• Resource limited countries networks• ART-LINC Collaboration• Treat Asia HIV Observational Database (TAHOD)
www.iedea-hiv.orgwww.art-linc.orgwww.amfar.org
International epidemiological Database to Evaluate AIDS (IeDEA)
IeDEA – West AfricaCoordinating Investigators
François DABIS (France)Emmanuel BISSAGNENE (Côte d’Ivoire)
Project ManagerDidier K. EKOUEVI
Progress report - February 2008
Adult clinical centers in West Africa (N = 16,945)Name Location Number of patients on HAART
USAC Côte d’Ivoire 2442
CePReF Côte d’Ivoire 3393
MTCT-Plus Côte d’Ivoire 461
SMIT Côte d’Ivoire 4608
CIRBA Côte d’Ivoire 2272
CNTS Côte d’Ivoire 716
Toure Hospital Mali 1113
Point G Mali 431
CNHU Benin 872
ANRS 1215 Senegal 404
MRC Gambia 233
Death probability in the first 12 months after ART initiation for 11 adult cohorts in West Africa
according to baseline CD4 count (N = 14,832)
9.4%
2.1%
4.6%
Retention of the patients in the 11 participating adult clinics in West Africa in the first 12 months
after ART initiation (N = 14,832 adults)
81.0%[81.3-82.6]
International epidemiological Database to evaluate AIDS (IeDEA) in West Africa
Cancer research proposal #1 - 2008
Prevalence of tobacco, alcohol and other recreational drugs use within HIV-infected
adult cohorts
International epidemiological Database to evaluate AIDS (IeDEA) in West Africa
Cancer research proposal #2 - 2008
HIV prevalence among patients hospitalized for malignancy in Abidjan (Côte d’Ivoire)
Paediatric ART in Sub-Saharan Africa:the multi-center KIDS-ART-LINC collaboration
Dabis, Mbori-NgachaANRS 12147 & NIH/OAR
To define prognosis of children treated with ART in sub-Saharan Africa in relation to the
type of treatment program
http://www.rcqhc.org/kids-art-linc
Scientific Output 2006-2007
• Site assessment and organization of collaboration published in Cohort Profile section of Int J Epidemiol 2007;doi:10.1093/ije/dym216
• First data merger completed (individual clinical data from 8 sites, 3644 children, 2.666 on ART)
• Two-year survival analysis done and results presented
o CROI 2007 (Los Angeles) – February 2007
o PEPFAR 2007 (Kigali) – June 2007
o Manuscript submitted
Delay in start ART until immunodeficiency results in excess mortality, most in 1st six months treatmentArrive CROI 2007 (cité par Mofenson - CROI 2008)
Months from ART start Probability of death after starting ART
Immune Deficient at Start ART
Not Immune Deficient at Start ART
6 months7.8% 1.8%
12 months 8.2% 2.2%
Meta-analysis 1,195 children from 8 African data bases53% >5 years of age, 66% severe age-related immune deficiency
ARV: NNRTI-based 58%, PI-based 37%
6% excess mortality0.4%after 6 mos
0.4%after 6 mos
KIDS-ART-LINC: Box 3, P. 24-25
QuickTime™ et undécompresseur TIFF (LZW)
sont requis pour visionner cette image.
Scientific perspectives 2008
• More analyses of the first merger :
– Sustained response to first-line ART regimens (durability, tolerance)
– Growth abnormalities and response to ART
– Incidence of tuberculosis, opportunistic infections, ART response in relation to prior PMTCT exposure cannot be investigated with the currently available data
• Repeat site assessment within IeDEA framework and/or specific survey on the practice of virological testing and viral resistance
• Initiate the development of a medico-economic model of pediatric care in Africa (“à la Freedberg”) using the KIDS-ART-LINC data set and network
• No new merger outside of very specific objectives
International epidemiological Databases to Evaluate AIDS
• 7 regional networks• North America• South America / Caribbean• West Africa• Central Africa• East Africa• Southern Africa• Australia / Asia
• Resource limited countries networks• KIDS-ART-LINC Collaboration• Treat Asia HIV Observational Database (TAHOD)
www.iedea-hiv.orgwww.anecca.orgwww.amfar.org
International epidemiological Database to Evaluate AIDS (IeDEA)
West AfricaPediatric Working group
Valériane Leroy, Alain Azondékon
Study population(N = 2204 children on HAART)
Country Center Number of Children under
HAART%
Bénin UPEIV 71 3
Côte d’Ivoire CePReF 309 14
Côte d’Ivoire CHU Yopougon 669 31
Côte d’Ivoire CIRBA 141 6
Côte d’Ivoire MTCT-Plus 74 3
Gambie FAJARA 23 1
Ghana Korle BU Hosp 128 6
Mali Hop G. Touré 674 31
Sénégal Hop A Royer 115 5
Total 2204 100
Bases de données observationnelles
Conclusions (février 2008) • L’ANRS seule ne peut pas maintenir des bases de
données internationales dans les pays à resources limitées : quid de la politique de sites ?
• Le partenariat avec les NIH est possible, mais : – La collaboration IeDEA est le nouveau cadre de référence – On ne pourra constituer de nouveaux “mergers” de
données inter-régionales (adultes ou pédiatriques) qu’en rapport avec des objectifs très spécifiques
• Réorienter les demandes de soutien à l’ANRS en fonction de ce nouveau contexte
Recommended